Wasfi Yasmine (CIK 2092127) reported 2 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-12-04). Recent activity: Sell SVRA (21,992 shares), Buy SVRA (35,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-12-04 | Savara Inc (SVRA) | Chief Medical Officer | Sell | 21,992 | $140,089 |
| 2025-10-22 | Savara Inc (SVRA) | Chief Medical Officer | Buy | 35,000 | $0 |
Source: SEC Form 4 filings · as of 2025-12-04